2002
DOI: 10.1542/peds.109.4.e67
|View full text |Cite
|
Sign up to set email alerts
|

Treatment of Plastic Bronchitis in a Fontan Patient With Tissue Plasminogen Activator: A Case Report and Review of the Literature

Abstract: ABSTRACT. Plastic bronchitis is a condition in which large, bronchial casts with rubber-like consistency develop in the tracheobronchial tree and cause airway obstruction. We describe a 4-year-old girl who had Fontan physiology and who developed plastic bronchitis and report for the first time the use of aerosolized tissue plasminogen activator for treatment of this condition. The literature is reviewed with emphasis placed on the occurrence of this disorder in patients with single ventricle physiology. Pediat… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

4
79
0
5

Year Published

2005
2005
2015
2015

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 96 publications
(88 citation statements)
references
References 23 publications
4
79
0
5
Order By: Relevance
“…Our case is unique in several aspects: a review of 15 patients who developed PB after undergoing Fontan surgery showed that a majority of postFontan PB had mucinous casts, but our patient's casts consisted of mucin, fibrin, and inflammatory cells, similar to those described by Costello et al 5 Secondly, our patient had normal extracardiac Fontan mean pressure of 11 mmHg, which is lower than the mean pressure of patients described in the literature .2,5 Our case did not have any of the risk factors as reported by Schumacher et al 2 that could have triggered an earlier therapeutic response.…”
Section: 2supporting
confidence: 79%
See 1 more Smart Citation
“…Our case is unique in several aspects: a review of 15 patients who developed PB after undergoing Fontan surgery showed that a majority of postFontan PB had mucinous casts, but our patient's casts consisted of mucin, fibrin, and inflammatory cells, similar to those described by Costello et al 5 Secondly, our patient had normal extracardiac Fontan mean pressure of 11 mmHg, which is lower than the mean pressure of patients described in the literature .2,5 Our case did not have any of the risk factors as reported by Schumacher et al 2 that could have triggered an earlier therapeutic response.…”
Section: 2supporting
confidence: 79%
“…al's 25 cases 2 of PB had an average post-Fontan PAP of 16.5 mmHg (range 12 to 22) compared to 43 non-PB Fontan patients with average PAP of 13 mmHg (range 12 to 15), but 39% of the non-FB patients did not have available PAP information. Costello et al 5 also reported a post-Fontan PB with lateral tunnel mean pressure of 10 mmHg, where the cast was found to consist of fibrin, mucin, and inflammatory cells. Tzifa et al 9 reported a case of postFontan PB where Fontan mean pressure was 13 mm Hg, the cast consisted of fibrin and neutrophils, and the cast culture grew Staphylococcus aureus.…”
Section: 2mentioning
confidence: 95%
“…There are, however, proposals that additional treatment be given, which could include corticosteroids (2 mg/kg/day, in the case of type I molds), 9 antibiotics 9 for associated bacterial conditions, broncho-alveolar lavage, respiratory physiotherapy and topical N-acetyl-cysteine (2 to 4 ml of 10% solution). [10][11][12] More recently, the use of thrombolytics in aerosol form (urokinase) and the endotracheal instillation of recombinant immunoglobulin (Dornase Alpha) have been described. 12 Mechanical removal of the molds under direct observation (bronchoscopy) can be very useful in cases of children with acute respiratory insufficiency.…”
Section: Discussionmentioning
confidence: 99%
“…Case studies have described the use of inhaled therapies [2,12,[53][54][55][56], anti-inflammatories [57,58], diuretics [38], and surgical palliation [34,35,59,60]. Brogan et al [2] incubated a cast from a Fontan patient in vitro with acetylcysteine, DNase, urokinase, and tPA, demonstrating that acetylcysteine had the greatest effect in dissolving the casts.…”
Section: Acute Managementmentioning
confidence: 99%
“…Quasney et al [56] 123 benefit for use of tPA in plastic bronchitis [36,61]. However, there has been reported effective use of inhaled tPA [55,62], and Wakeham et al [63] showed long-term and efficacious therapy over the course of 18 months without any adverse complications. A murine model studied the safety of prolonged, repeated administration of inhaled pulmonary formulation tPA [64].…”
Section: Acute Managementmentioning
confidence: 99%